Researchers into the remarkable properties of oxytocin have delivered even more exciting news recently, announcing that the spray version of the cuddle hormone may alleviate the symptoms of social awkwardness found in patients with mild forms of autism.

Speculation has been taking place for sometime that oxytocin, a hormone that helps people to bond and emphasise with each other (thus the ‘cuddle hormone’) may form the basis of future treatments of the autistic.  This study, carried out by a French government department, is the first to establish that oxytocin does indeed appear to alleviate the symptoms of autistic patients.
The findings offer hope to the 500,000 people in Britain with autism and related disorders.

Current treatment is limited to drugs that control aggression and behavioural therapies.

Spray version of the cuddle hormone can ease symptoms of autism